Razid-20

Razid-20 Dosage/Direction for Use

rabeprazole

Manufacturer:

Saga Lab

Distributor:

KTZ
Full Prescribing Info
Dosage/Direction for Use
For oral administration.
Adults/elderly: Active Duodenal Ulcer and Active Benign Gastric Ulcer: 20 mg to be taken once daily in the morning.
Erosive or Ulcerative Gastro-Oesophageal Reflux Disease (GORD): 20 mg to be taken once daily for four to eight weeks.
Gastro-Oesophageal Reflux Long-term Management (GORD Maintenance): For longterm management up to 12 months, a maintenance dose of RAZID 10 mg once daily can be used. Some patients may respond to a maintenance dose of 10 mg/day.
Eradication of H. pylori: RAZID 20 is indicated for H. pylori-positive duodenal ulcers, as part of the eradication programme with appropriate antibiotics.
Renal and hepatic impairment: No dosage adjustment is necessary for patients with renal or hepatic impairment.
Caution is however advised when RAZID 20 is first initiated in patients with severe hepatic dysfunction.
Children: RAZID is not recommended for use in children, as there is no experience of its use in this group.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in